TOPIC
Quantifying Glaucomatous Neurodegeneration Using Diffusion MRI
SPEAKER
Lloyd Plumart
Doctoral Candidate in Visual Neuroscience
University Medical Center Groningen
We look with our eyes, but we see with our brain. The brain plays a crucial part in how we process visual information. When people lose their vision due to eye diseases such as Glaucoma, it is expected that structural changes are present in the primary visual pathway of the brain as well. Using advanced imaging modalities such as diffusion MRI, we are able to quantify and visualise these structural changes and relate these to vision loss and structural changes in the eye.
Join Us
Sunday, April 12th, 2026
10:30 AM (BST), 3:00 PM (IST), 11:30 AM (CET)
Click Below to Register 👇
e-Certificates available on request for a small processing fee*
Premium Members (MVSA) will receive a Complementary Certificate of Attendance with 2 Knowledge Points for attending this event.
Speaker Bio:-

Lloyd Plumart is a biomedical engineer from Belgium. His academic background is mainly in medical imaging, with a strong focus on diffusion MRI. While pursuing his engineering degree, he has developed improved image reconstruction methods in ultra-low-dose PET imaging using deep learning, developed automatic sleep staging classification algorithms using machine learning, and eventually did his master’s thesis on test-retest reliability of preclinical diffusion MRI where he got in contact with MRI analysis for the first time. Currently, he is affiliated to the University Medical Center of Groningen and working as a doctoral candidate in visual neuroscience in the European Marie Skłodowska-Curie Actions program EGRET-AAA. Concretely, he develops advanced diffusion MRI techniques to better quantify neurodegeneration in the primary visual pathway in people with Glaucoma. He aims to describe the location, direction, and speed at which axons degenerate in the brain to give insights into the underlying mechanisms of neuronal degeneration in Glaucoma. Understanding how the brain reacts to a pathology like Glaucoma will be crucial when developing and assessing the efficacy of neuroregenerative medicine. It is only through this doctoral program that he was able to get in contact with vision science. He has become knowledgeable on how vision works, both on the level of the eye and on the level of the brain. With his technical background, he hopes to bring together the world of engineering and medicine such that the complex mechanisms behind these diseases can be understood and described in an all-encompassing manner.

Recent Comments